Cancer vaccine - Vaxine
Latest Information Update: 03 Mar 2023
Price :
$50 *
At a glance
- Originator Vaxine
- Class Antineoplastics; Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 07 Feb 2023 Preclinical trials in Cancer in Australia (Parenteral) (Prior to February 2023) (Vaxine pipeline, February 2023)